Trial in Adult Subjects With Acute Migraines

Completed · Phase 3 · Has a placebo group

Conditions studied: Migraine, With or Without Aura

In brief

The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant ODT) versus placebo in subjects with Acute Migraines.

Key facts

Study ID
NCT03461757
Run by
Pfizer
People needed
1811
Starts
2018-02-27
Expected to finish
2018-10-15
Last updated by the study team
2023-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.